Advertisement

Research Summaries

FDA Alert
FDA Alert
03/21/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved resmetirom for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis with moderate-to-advanced liver fibrosis.
03/21/2024
FDA Alert
FDA Alert
09/11/2023

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approval follows a single-arm, multicenter, open-label trial in 91 patients with uveal melanoma with unresectable hepatic metastases.
09/11/2023
Research Summary
Research Summary
06/28/2023
Based on recent scientific knowledge, the American Diabetes Association (ADA) released a set of updates including recommendations for the detection and management of nonalcoholic fatty liver disease in...
06/28/2023
research summary
research summary
04/26/2023

Leigh Precopio

Leigh Precopio
To better understand the relationship between cardiovascular disease and liver disease in individuals with HIV, researchers examined both traditional risk factors and HIV-specific risk factors of the...
04/26/2023
Research Summary
Research Summary
02/01/2023
The researchers set out to determine the mortality risk and complications associated with direct-acting antiviral treatment in patients with chronic hepatitis C.
02/01/2023
Obesity
Obesity
12/05/2022
Researchers identified the prevalence of non-alcoholic fatty liver disease (NAFLD), non-alcoholic fatty liver (NAFL), and non-alcoholic steatohepatitis (NASH) in individuals who are overweight or obese. ...
12/05/2022
mortality
mortality
06/29/2022
To better understand mortality trends within the United States, researchers examined the rate of death in people who died of alcohol-related liver disease.
06/29/2022
Liver Disease
Liver Disease
12/08/2020
The researchers examined the prevalence of steatosis, nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis in individuals with metabolically healthy obesity and metabolically abnormal obesity...
12/08/2020
Liver Disease
Liver Disease
10/20/2020
A research team has determined the risk factors for moderate to severe hepatic steatosis among patients with HIV by comparing the prevalence rates of hepatic steatosis among patients with HIV vs without...
10/20/2020
Liver Disease
Liver Disease
07/24/2019
The USPSTF evaluated the effectiveness and potential harms of screening for hepatitis B virus.
07/24/2019